The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
27 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,102,398 in first-year total cost, median $39,772.
Most frequent study sections
- Special Emphasis Panel[ZCA1 PCRB-H (M1)]27
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- CASE WESTERN RESERVE UNIVERSITY1
- CORNELL UNIVERSITY1
- DUKE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Identification of therapeutic targets in clonal hematopoiesis1F99CA274656-01 | WAARTS, MICHAEL R | SLOAN-KETTERING INST CAN RESEARCH, NY | $48,252 | ZCA1 |
| 2022 | Engineering Next-Generation Nanoparticles One Layer at a Time1F99CA274651-01 | SUSIN PIRES, IVAN | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $48,252 | ZCA1 |
| 2022 | Genetic and immunological dissection of coinhibitory crosstalks between human T cells and cancer cells1F99CA274708-01 | OGISHI, MASATO | ROCKEFELLER UNIVERSITY, NY | $48,252 | ZCA1 |
| 2022 | Decoding hyperexcitability in malignant glioma1F99CA274700-01 | CURRY, RACHEL NAOMI | BAYLOR COLLEGE OF MEDICINE, TX | $48,252 | ZCA1 |
| 2022 | Diabetes Mellitus Promotes Breast Tumor Progression via Glycation Mediated Matrix Stiffening1F99CA274695-01 | WANG, WENJUN | VANDERBILT UNIVERSITY, TN | $48,252 | ZCA1 |
| 2022 | Utilization of Fasting Mimicking Diets to Treat and Prevent Clear Cell Renal Cell Carcinoma1F99CA274694-01 | MURPHY, SEAN | UNIVERSITY OF NOTRE DAME, IN | $48,252 | ZCA1 |
| 2022 | Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy1F99CA274690-01 | HU, YUESONG | EMORY UNIVERSITY, GA | $48,252 | ZCA1 |
| 2022 | Myeloid cell-expressed PTPN22 and anti-tumor immunity1F99CA274689-01 | ACERO BEDOYA, SANTIAGO | UNIVERSITY OF CHICAGO, IL | $48,252 | ZCA1 |
| 2022 | Keratin-dependent regulation of progenitor keratinocyte identity and commitment to differentiation1F99CA274517-01 | REDMOND, CATHERINE JULIA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $44,793 | ZCA1 |
| 2022 | SIRT1 Regulates RNA Stability to Promote Breast Cancer1F99CA274706-01 | WANG, FANGYU | CORNELL UNIVERSITY, NY | $44,732 | ZCA1 |
| 2022 | Elucidating the role of RNA splicing in the metastatic seeding and outgrowth of aggressive cancers.1F99CA274597-01 | PARKER, KIMBERLY | CASE WESTERN RESERVE UNIVERSITY, OH | $43,719 | ZCA1 |
| 2022 | Oncogenic Kras drives stromal adipogenesis to promote colorectal cancer (CRC) progression1F99CA274661-01 | HSU, WEN-HAO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $42,114 | ZCA1 |
| 2022 | Regulation and retention of extrachromosomal oncogene amplifications in cancer1F99CA274692-01 | HUNG, KING L. | STANFORD UNIVERSITY, CA | $41,065 | ZCA1 |
| 2022 | Drug Retention and Tumor Distribution of Polymeric Micelles for Cancer Therapy1F99CA274702-01 | RAMSEY, JACOB DAGGETT | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $39,772 | ZCA1 |
| 2022 | Chromatin remodeling in CD8+ T cells and harnessing stromal-immune interactions for effective antitumor immunity1F99CA274688-01 | MCDONALD, BRYAN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $39,424 | ZCA1 |
| 2022 | Enhancing the antitumor effect of radiation therapy by targeting the cGAS-STING pathway1F99CA274647-01 | FANG, YAN | UT SOUTHWESTERN MEDICAL CENTER, TX | $37,263 | ZCA1 |
| 2022 | Investigation of tumor stem cell maintenance and cellular hierarchy in pediatric high-grade glioma1F99CA274654-01 | DESISTO, JOHN A | UNIVERSITY OF COLORADO DENVER, CO | $36,896 | ZCA1 |
| 2022 | Integrated Epidemiologic Study of Ultra-processed Foods and Colorectal Cancer Survival1F99CA274714-01 | DU, MENGXI | TUFTS UNIVERSITY BOSTON, MA | $36,141 | ZCA1 |
| 2022 | Discovery of diverse nucleotide immune signals for use as novel immunotherapies1F99CA274660-01 | SLAVIK, KAILEY | HARVARD MEDICAL SCHOOL, MA | $36,134 | ZCA1 |
| 2022 | Transcriptional Regulation of Peripheral Immune Cells as a Modulator of Melanoma Immunotherapy Resistance and Toxicity1F99CA274650-01 | MONSON, KELSEY R | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $35,985 | ZCA1 |
| 2022 | The role of the CCR4-NOT complex in the regulation of Nuclear Pore Complex assembly1F99CA274682-01 | SAKUMA, STEPHEN | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $35,852 | ZCA1 |
| 2022 | Gene Therapy for the Treatment of Neurofibromatosis Type I (NF1)1F99CA274707-01 | SITTON, MADELEINE JANETTE | DUKE UNIVERSITY, NC | $34,748 | ZCA1 |
| 2022 | Precision Approaches to Treat Mantle Cell Lymphoma: Integrating Multi-omics Based Models1F99CA274686-01 | HILL, HOLLY ANN | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $34,680 | ZCA1 |
| 2022 | Impact of Numeracy on Risk Perceptions of Tobacco-Related Diseases1F99CA274655-01 | DIAZ, DESTINY | ROSWELL PARK CANCER INSTITUTE CORP, NY | $33,780 | ZCA1 |
| 2022 | Role of nuclear chaperones in genomic instability and carcinogenesis1F99CA274696-01 | KUPPA, SAHITI | SAINT LOUIS UNIVERSITY, MO | $33,752 | ZCA1 |
| 2022 | Improving the Generalizability of Deep Neural Networks by Teaching them Lung Cancer Pathophysiology1F99CA274713-01 | MASQUELIN, AXEL HERVE PATRICK | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $33,190 | ZCA1 |
| 2022 | Targeting a Novel Pocket on ITGAV1F99CA274649-01 | MATTSON, NICOLE | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $32,342 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.